Significantly, barring one tumor from deceased and two tumors from alive patients, deceased patient tumors had mixed NOS2 and CD8+ T cell levels, which could be separated into both NOS2 and CD8 low immune desert regions and NOS2 high, stroma-restricted CD8+ T-cell inflamed regions (Fig. 2D). This evidence concerns the gene CD8A and neoplasm.